1. Home
  2. EVGO vs CADL Comparison

EVGO vs CADL Comparison

Compare EVGO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGO
  • CADL
  • Stock Information
  • Founded
  • EVGO 2010
  • CADL 1999
  • Country
  • EVGO United States
  • CADL United States
  • Employees
  • EVGO N/A
  • CADL N/A
  • Industry
  • EVGO Other Specialty Stores
  • CADL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVGO Consumer Discretionary
  • CADL Health Care
  • Exchange
  • EVGO Nasdaq
  • CADL Nasdaq
  • Market Cap
  • EVGO N/A
  • CADL 306.4M
  • IPO Year
  • EVGO N/A
  • CADL 2021
  • Fundamental
  • Price
  • EVGO $2.76
  • CADL $8.06
  • Analyst Decision
  • EVGO Strong Buy
  • CADL Strong Buy
  • Analyst Count
  • EVGO 10
  • CADL 4
  • Target Price
  • EVGO $6.11
  • CADL $21.00
  • AVG Volume (30 Days)
  • EVGO 3.7M
  • CADL 1.2M
  • Earning Date
  • EVGO 03-04-2025
  • CADL 03-13-2025
  • Dividend Yield
  • EVGO N/A
  • CADL N/A
  • EPS Growth
  • EVGO N/A
  • CADL N/A
  • EPS
  • EVGO N/A
  • CADL N/A
  • Revenue
  • EVGO $256,825,000.00
  • CADL N/A
  • Revenue This Year
  • EVGO $42.11
  • CADL N/A
  • Revenue Next Year
  • EVGO $30.36
  • CADL N/A
  • P/E Ratio
  • EVGO N/A
  • CADL N/A
  • Revenue Growth
  • EVGO 59.57
  • CADL N/A
  • 52 Week Low
  • EVGO $1.65
  • CADL $1.40
  • 52 Week High
  • EVGO $9.07
  • CADL $14.60
  • Technical
  • Relative Strength Index (RSI)
  • EVGO 50.16
  • CADL 45.77
  • Support Level
  • EVGO $2.33
  • CADL $8.33
  • Resistance Level
  • EVGO $2.82
  • CADL $9.08
  • Average True Range (ATR)
  • EVGO 0.18
  • CADL 0.59
  • MACD
  • EVGO 0.07
  • CADL -0.04
  • Stochastic Oscillator
  • EVGO 90.98
  • CADL 42.70

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: